Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine
about
Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal developmentRole of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1Comparison of the effects of the novel vasodilator FK409 with those of nitroglycerin in isolated coronary artery of the dogCyclic nucleotide phosphodiesterase 1 and vascular agingPhosphodiesterase inhibitors: new opportunities for the treatment of asthma.Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats.Novel alternative splice variants of cGMP-binding cGMP-specific phosphodiesterase.The catalytic subunit of protein kinase A triggers activation of the type V cyclic GMP-specific phosphodiesterase from guinea-pig lung.Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra).Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells.Inhibition of phosphodiesterase 1 augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs with acute pulmonary hypertension.An update on vinpocetine: New discoveries and clinical implications.
P2860
Q28581454-714ABDE6-0633-43B0-A281-47CE8885ACA0Q33577131-08D4DFE8-6AF1-4A09-B480-A8C263ACFB7CQ34780141-5C959680-D911-4026-B6DD-37D98193AE69Q35871159-AA2FC0E6-AC38-4525-B444-6375578F7051Q36175455-40F12AD2-201F-465E-9431-1C19B9F7C5A7Q37260479-1BE399D0-7E47-4E47-8982-60C7D7CA3522Q37351285-C2E5A9F5-E5C4-4F22-BC3F-3D922923F1F5Q38332843-70B9803A-A6B8-4757-9513-E873283B95C5Q42221795-C7B323E0-D722-4C22-8B26-E29FF709BA95Q45220029-ECD39350-1388-4838-9082-5A2830723746Q46406301-5D3FE7CA-69E7-4005-9818-446F49BAD615Q46801126-1D7DB748-B34F-4674-B27B-D2C8892158E2Q49567493-4A719891-FB5A-4728-87EC-CC78D5E90139
P2860
Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Role of selective cyclic GMP p ...... obutyl-8-(methylamino)xanthine
@en
Role of selective cyclic GMP p ...... obutyl-8-(methylamino)xanthine
@nl
type
label
Role of selective cyclic GMP p ...... obutyl-8-(methylamino)xanthine
@en
Role of selective cyclic GMP p ...... obutyl-8-(methylamino)xanthine
@nl
prefLabel
Role of selective cyclic GMP p ...... obutyl-8-(methylamino)xanthine
@en
Role of selective cyclic GMP p ...... obutyl-8-(methylamino)xanthine
@nl
P2093
P2860
P1476
Role of selective cyclic GMP p ...... obutyl-8-(methylamino)xanthine
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1989.TB14599.X
P407
P577
1989-11-01T00:00:00Z